US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Capstead Mortgage

6.50

+0.0000

Volume:- -

Turnover:- -

Market Cap:629.69M

PE:9.25

High:6.50

Open:6.50

Low:6.50

Close:6.50

Loading ...

Overview Company News Filings

I-Mab to Participate at the Truist Securities BioPharma Symposium

Clearfield CMO Kevin Morgan switches to advisor role, Anis Khemakhem to succeed

Clearfield Appoints Anis Khemakhem as CMO; Kevin Morgan Takes on New Role as Executive Advisor to the CEO

Press Release: Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

AdAlta secures top talent to lead AdCella and AdSolis as boost in clinical activity looms

Press Release: Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting

Closing Bell: WiseTech drags again; 29Metals sinks 20pc on copper output

ASX Small Caps Lunch Wrap: ASX up, and things are pretty quiet for a Wednesday

Nxera Pharma to Host R&D Day 2024

Press Release: First Citizens Bank Names Chief Marketing Officer

89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024

Binance CMO Rachel Conlan Talks Regional Growth, Crypto Adoption, and Community

Optimi Health appoints Parisa Zamiri as CMO, Tom Reilly as CFO

Opthea Appoints Chief Medical Officer and Chief Financial Officer as Company Prepares for Phase 3 Topline Data Readouts in 2025

Press Release: Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer

Allarity names Jeremy Graff as president, CDO, Jose Iglesias as consultant CMO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CMO/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMO"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMO\",,,,,undefined,":{"symbol":"CMO","market":"US","secType":"STK","nameCN":"Capstead Mortgage","latestPrice":6.5,"timestamp":1683316800000,"preClose":6.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"change":0,"floatShares":94511941,"shares":96875560,"eps":0.70279,"lyrEps":-1.561156,"pbRate":1.01,"amount":0,"amplitude":0,"dividePrice":0.6,"prevYearClose":5.81},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMO\",,,,,undefined,":{"symbol":"CMO","floatShares":94511941,"roa":"1.05%","roe":"9.73%","lyrEps":-1.561156,"shares":96875560,"dividePrice":0.6,"high":6.5,"amplitude":0,"preClose":6.5,"low":6.5,"week52Low":5.06,"pbRate":"1.01","week52High":7,"institutionHeld":0.6556,"latestPrice":6.5,"eps":0.70279,"divideRate":0.092308,"volume":0,"delay":0,"ttmEps":0.70279,"open":6.5,"prevYearClose":5.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-10-19","symbol":"CMO","reason":null,"defaultRemindTime":1634650200000,"announcedDate":"2021-10-14","type":"delisting","dateTimestamp":1634616000000},{"market":"US","date":"2021-09-29","symbol":"CMO","amount":0.0725,"defaultRemindTime":1632922200000,"name":"卡帕史丹抵押","recordDate":"2021-10-15","payableDate":"2021-09-30","currency":"USD","type":"dividend","dateTimestamp":1632888000000},{"market":"US","date":"2021-07-28","symbol":"CMO","fiscalQuarterEnding":"2021/06","expectedEps":0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1627444800000,"reportTimeType":"post","actualEps":0.09},{"market":"US","date":"2021-06-29","symbol":"CMO","amount":0.15,"defaultRemindTime":1624973400000,"name":"卡帕史丹抵押","recordDate":"2021-07-20","payableDate":"2021-06-30","currency":"USD","type":"dividend","dateTimestamp":1624939200000},{"market":"US","date":"2021-04-28","symbol":"CMO","fiscalQuarterEnding":"2021/03","expectedEps":0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1619582400000,"reportTimeType":"post","actualEps":0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMO\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-20","value":0.21,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-20","value":0.21,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-20","value":0.19,"currency":"USD"},{"executeDate":"2017-12-28","recordDate":"2017-12-29","paymentDate":"2018-01-19","value":0.19,"currency":"USD"},{"executeDate":"2018-03-28","recordDate":"2018-03-29","paymentDate":"2018-04-20","value":0.16,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMO\",params:#withValueCompare:true,withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMO","date":"2021-10-15","current":7.640996,"percent":0.314859,"low":-22.34847,"twenty":-2.345067,"median":8.952272,"eighty":9.977375,"high":12.421044,"avg":5.832951,"sd":6.794752,"marketCap":663597586},"quantilePoints":[{"date":"2020-03-20","current":-8.384079,"twenty":7.238212,"median":9.013153,"eighty":9.961637,"marketCap":296276574},{"date":"2020-03-27","current":-13.719402,"twenty":7.223837,"median":9.003038,"eighty":9.961637,"marketCap":484816212},{"date":"2020-04-03","current":-8.91988,"twenty":7.18316,"median":8.990183,"eighty":9.961637,"marketCap":315210711},{"date":"2020-04-09","current":-13.802627,"twenty":7.179535,"median":8.982272,"eighty":9.960108,"marketCap":487757247},{"date":"2020-04-17","current":-12.793344,"twenty":7.148263,"median":8.969195,"eighty":9.961637,"marketCap":452091203},{"date":"2020-04-24","current":-12.902456,"twenty":7.078887,"median":8.959161,"eighty":9.961637,"marketCap":455946992},{"date":"2020-05-01","current":-13.338903,"twenty":7.056071,"median":8.952272,"eighty":9.961637,"marketCap":471370146},{"date":"2020-05-08","current":-2.058678,"twenty":7.030259,"median":8.94381,"eighty":9.961637,"marketCap":478117776},{"date":"2020-05-15","current":-1.959065,"twenty":7.014387,"median":8.94381,"eighty":9.961637,"marketCap":454983045},{"date":"2020-05-22","current":-2.125087,"twenty":7.006826,"median":8.94381,"eighty":9.961637,"marketCap":493540930},{"date":"2020-05-29","current":-2.100184,"twenty":6.985716,"median":8.94381,"eighty":9.961637,"marketCap":487757247},{"date":"2020-06-05","current":-2.353368,"twenty":6.971413,"median":8.94381,"eighty":9.961637,"marketCap":546558022},{"date":"2020-06-12","current":-2.324314,"twenty":6.94205,"median":8.94381,"eighty":9.961637,"marketCap":539810392},{"date":"2020-06-19","current":-2.270357,"twenty":6.929442,"median":8.94381,"eighty":9.961637,"marketCap":527279080},{"date":"2020-06-26","current":-2.282809,"twenty":6.908337,"median":8.94381,"eighty":9.961637,"marketCap":530170921},{"date":"2020-07-02","current":-2.241303,"twenty":6.880197,"median":8.94381,"eighty":9.961637,"marketCap":520531450},{"date":"2020-07-10","current":-2.212249,"twenty":6.861906,"median":8.94381,"eighty":9.961637,"marketCap":513783820},{"date":"2020-07-17","current":-2.407326,"twenty":6.832359,"median":8.94381,"eighty":9.961637,"marketCap":559089335},{"date":"2020-07-24","current":-2.43638,"twenty":6.818289,"median":8.94381,"eighty":9.961637,"marketCap":565836965},{"date":"2020-07-31","current":-2.552595,"twenty":6.804219,"median":8.94381,"eighty":9.961637,"marketCap":592827484},{"date":"2020-08-07","current":-4.061327,"twenty":6.783114,"median":8.94381,"eighty":9.961637,"marketCap":593282683},{"date":"2020-08-14","current":-4.200006,"twenty":6.760603,"median":8.94381,"eighty":9.961637,"marketCap":613541116},{"date":"2020-08-21","current":-4.094346,"twenty":6.628662,"median":8.94381,"eighty":9.961637,"marketCap":598106119},{"date":"2020-08-28","current":-4.173591,"twenty":6.575134,"median":8.94381,"eighty":9.961637,"marketCap":609682367},{"date":"2020-09-04","current":-4.008497,"twenty":6.549871,"median":8.94381,"eighty":9.961637,"marketCap":585565185},{"date":"2020-09-11","current":-3.902836,"twenty":6.541892,"median":8.94381,"eighty":9.961637,"marketCap":570130188},{"date":"2020-09-18","current":-4.094346,"twenty":6.521948,"median":8.94381,"eighty":9.961637,"marketCap":598106119},{"date":"2020-09-25","current":-3.816987,"twenty":6.508651,"median":8.94381,"eighty":9.961637,"marketCap":557589253},{"date":"2020-10-02","current":-3.757553,"twenty":6.490036,"median":8.94381,"eighty":9.961637,"marketCap":548907068},{"date":"2020-10-09","current":-3.889628,"twenty":6.462113,"median":8.94381,"eighty":9.961637,"marketCap":568200813},{"date":"2020-10-16","current":-3.757553,"twenty":6.43552,"median":8.94381,"eighty":9.961637,"marketCap":548907068},{"date":"2020-10-23","current":-3.744345,"twenty":6.408927,"median":8.94381,"eighty":9.961637,"marketCap":546977693},{"date":"2020-10-30","current":-3.374963,"twenty":6.396659,"median":8.94381,"eighty":9.961637,"marketCap":493017910},{"date":"2020-11-06","current":-4.133915,"twenty":6.382334,"median":8.94381,"eighty":9.961637,"marketCap":496875857},{"date":"2020-11-13","current":-4.454995,"twenty":6.375541,"median":8.94381,"eighty":9.961637,"marketCap":535468156},{"date":"2020-11-20","current":-4.559347,"twenty":6.370072,"median":8.94381,"eighty":9.961637,"marketCap":548010654},{"date":"2020-11-27","current":-4.703833,"twenty":6.339686,"median":8.94381,"eighty":9.961637,"marketCap":565377189},{"date":"2020-12-04","current":-4.888454,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":587567761},{"date":"2020-12-11","current":-4.735941,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":569236419},{"date":"2020-12-18","current":-4.800157,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":576954879},{"date":"2020-12-24","current":-4.679752,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":562482766},{"date":"2020-12-31","current":-4.615536,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":554764306},{"date":"2021-01-08","current":-4.615536,"twenty":6.368159,"median":8.946403,"eighty":9.966491,"marketCap":554764306},{"date":"2021-01-15","current":-4.567374,"twenty":6.368159,"median":8.946403,"eighty":9.966491,"marketCap":548975461},{"date":"2021-01-22","current":-4.639617,"twenty":6.368159,"median":8.946403,"eighty":9.966491,"marketCap":557658729},{"date":"2021-01-29","current":-4.005977,"twenty":6.368159,"median":8.946403,"eighty":9.966491,"marketCap":519066429},{"date":"2021-02-05","current":-4.147452,"twenty":6.382334,"median":8.952088,"eighty":9.972174,"marketCap":537397771},{"date":"2021-02-12","current":-4.955732,"twenty":6.382334,"median":8.952088,"eighty":9.972174,"marketCap":642129114},{"date":"2021-02-19","current":-4.818073,"twenty":6.376126,"median":8.952088,"eighty":9.972174,"marketCap":624292194},{"date":"2021-02-26","current":-4.279938,"twenty":6.309203,"median":8.952088,"eighty":9.972174,"marketCap":554564395},{"date":"2021-03-05","current":-4.459202,"twenty":-1.961556,"median":8.95218,"eighty":9.973908,"marketCap":577792223},{"date":"2021-03-12","current":-4.735568,"twenty":-2.042907,"median":8.95218,"eighty":9.973908,"marketCap":613601791},{"date":"2021-03-19","current":-4.705691,"twenty":-2.110146,"median":8.952272,"eighty":9.975641,"marketCap":609730487},{"date":"2021-03-26","current":-4.743038,"twenty":-2.149161,"median":8.95218,"eighty":9.973908,"marketCap":614569617},{"date":"2021-04-01","current":-4.653405,"twenty":-2.212249,"median":8.95218,"eighty":9.973908,"marketCap":602955703},{"date":"2021-04-09","current":-4.776135,"twenty":-2.241303,"median":8.952272,"eighty":9.975641,"marketCap":618858144},{"date":"2021-04-16","current":-4.798558,"twenty":-2.282809,"median":8.952272,"eighty":9.975641,"marketCap":621763582},{"date":"2021-04-23","current":-4.746237,"twenty":-2.322654,"median":8.952272,"eighty":9.975641,"marketCap":614984228},{"date":"2021-04-30","current":6.63356,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":623700540},{"date":"2021-05-07","current":6.674762,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":627574456},{"date":"2021-05-14","current":6.551155,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":615952707},{"date":"2021-05-21","current":6.674762,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":627574456},{"date":"2021-05-28","current":6.654161,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":625637498},{"date":"2021-06-04","current":6.674762,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":627574456},{"date":"2021-06-11","current":6.952877,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":653723392},{"date":"2021-06-18","current":6.695363,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":629511415},{"date":"2021-06-25","current":6.520253,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":613047270},{"date":"2021-07-02","current":6.437849,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":605299437},{"date":"2021-07-09","current":6.149433,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":578182022},{"date":"2021-07-16","current":6.221537,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":584961376},{"date":"2021-07-23","current":6.27304,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":589803771},{"date":"2021-07-30","current":7.259662,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":630479894},{"date":"2021-08-06","current":7.105569,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":617097317},{"date":"2021-08-13","current":7.228271,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":627753628},{"date":"2021-08-20","current":7.217116,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":626784873},{"date":"2021-08-27","current":7.618687,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":661660074},{"date":"2021-09-03","current":7.730234,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":671347630},{"date":"2021-09-10","current":7.707924,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":669410119},{"date":"2021-09-17","current":7.730234,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":671347630},{"date":"2021-09-24","current":7.69677,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":668441364},{"date":"2021-10-01","current":7.46252,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":648097496},{"date":"2021-10-08","current":7.741389,"twenty":-2.345067,"median":8.952272,"eighty":9.977375,"marketCap":672316386},{"date":"2021-10-15","current":7.640996,"twenty":-2.345067,"median":8.952272,"eighty":9.977375,"marketCap":663597586}],"customCompares":[],"updateTime":1742121304721},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMO\",pageSize:16,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2478976105","title":"I-Mab to Participate at the Truist Securities BioPharma Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2478976105","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478976105?lang=en_us&edition=fundamental","pubTime":"2024-10-28 19:00","pubTimestamp":1730113200,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Oct. 28, 2024 /PRNewswire/ --I-Mab , a US-based, global, biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will participate in one-on-one and small group meetings with investors at the Truist Securities BioPharma Symposium on November 7, 2024.Sean Fu, PhD, MBA, Interim Chief Executive Officer  Joe Skelton, Chief Financial Officer  Phillip Dennis, MD, PhD, Chief Medical Officer  Tyler Ehler, Senior Director, Investor Relations. For more information, please contact your Truist Securities representative.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/YY4cMKzXvpZlyMc6OlKWdw--~B/aD0xNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/eb81d0c969528762bc858c941b7a51e6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/YY4cMKzXvpZlyMc6OlKWdw--~B/aD0xNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/eb81d0c969528762bc858c941b7a51e6"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/mab-participate-truist-securities-biopharma-110000380.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mab-participate-truist-securities-biopharma-110000380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","CEO","IMAB","BK4139","SQQQ","PSQ","QID","BK4526","CFO",".IXIC","QLD","NQmain","TQQQ","CMO","MNQmain","BK4535"],"gpt_icon":1},{"id":"2477636433","title":"Clearfield CMO Kevin Morgan switches to advisor role, Anis Khemakhem to succeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2477636433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477636433?lang=en_us&edition=fundamental","pubTime":"2024-10-24 21:11","pubTimestamp":1729775482,"startTime":"0","endTime":"0","summary":"Clearfield (CLFD) announced a strategic leadership transition, appointing Anis Khemakhem as chief marketing officer, or CMO, effective January 1, 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearfield-cmo-kevin-morgan-switches-to-advisor-role-anis-khemakhem-to-succeed?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearfield-cmo-kevin-morgan-switches-to-advisor-role-anis-khemakhem-to-succeed?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMO","LU0314104364.USD","LU1989772840.SGD","LU1989772923.USD","BK4127","LU0106831901.USD","BK4585","LU0267386448.USD","LU1363072403.SGD","CLFD","LU1720051108.HKD","BK4504","LU0320765646.SGD","BK4020","LU2357305700.SGD","BK4534","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1074936037.SGD","LU1720051017.SGD","LU1548497426.USD","LU1668664300.SGD","LU0225283273.USD","LU1162221912.USD","LU0971096721.USD","LU0098860793.USD","BK4581","BK4588"],"gpt_icon":0},{"id":"2477631567","title":"Clearfield Appoints Anis Khemakhem as CMO; Kevin Morgan Takes on New Role as Executive Advisor to the CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2477631567","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477631567?lang=en_us&edition=fundamental","pubTime":"2024-10-24 21:00","pubTimestamp":1729774800,"startTime":"0","endTime":"0","summary":"Leadership transition sets the stage for continued growth and innovation in fiber broadband solutions. MINNEAPOLIS, October 24, 2024----Clearfield, Inc. , the leader in community broadband fiber connectivity, today announced a strategic leadership transition, appointing Anis Khemakhem as Chief Marketing Officer  effective January 1, 2025. Khemakhem, who joined Clearfield earlier this year as Vice President of Global Technology Platforms, brings with him over 25 years of industry experience, with diverse leadership skills.Kevin Morgan, who has served as Clearfield’s CMO since 2016, will transition into the newly created role of Executive Advisor to the CEO, continuing to contribute to the company’s growth and industry leadership. In this role, Morgan will maintain Clearfield’s connection with the Fiber Broadband Association , supporting public policy efforts while also representing Clearfield at select industry conferences and authoring articles for industry-leading publications. Levera","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tbJs0D5SLoIMI7NEnFRVGQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2669118228129cdd2eebd5a027ea1788","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tbJs0D5SLoIMI7NEnFRVGQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2669118228129cdd2eebd5a027ea1788"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/clearfield-appoints-anis-khemakhem-cmo-130000353.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2357305700.SGD","CLFD","LU1548497426.USD","LU1720051017.SGD","IE00BZ1G4Q59.USD","BK4581","BK4504","CMO","LU1989772923.USD","BK4585","LU0106831901.USD","IE00BKVL7J92.USD","LU1989772840.SGD","LU0971096721.USD","LU0225283273.USD","LU0267386448.USD","LU1720051108.HKD","BK4127","LU1162221912.USD","BK4588","LU0098860793.USD","LU0320765646.SGD","LU0314104364.USD","LU1074936037.SGD","LU1668664300.SGD","LU1363072403.SGD","BK4534","BK4020"],"gpt_icon":0},{"id":"2477689957","title":"Press Release: Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2477689957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477689957?lang=en_us&edition=fundamental","pubTime":"2024-10-24 19:30","pubTimestamp":1729769400,"startTime":"0","endTime":"0","summary":"NEW YORK and MELBOURNE, Australia, Oct. 24, 2024  -- Incannex Healthcare Inc. , , a clinical-stage biopharmaceutical company developing innovative medicines for people with chronic diseases and significant unmet medical needs, today announced the appointment of Lou Barbato, M.D., as Chief Medical Officer  effective immediately. Dr. Barbato's drug development experience includes senior clinical development and operational roles at Jazz Pharmaceuticals, AbbVie, Biogen, Novartis, and Solvay. He joins Incannex as the company continues to advance its lead clinical-stage programs in obstructive sleep apnea, generalized anxiety disorder, and rheumatoid arthritis.\"We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product launches, Lou is a valuable addition to the Incannex team,\" said Joel Latham, Incannex's President and Chief Executive Officer. \"Lou's","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","R","BK4232","BK4532","GSK","IH","CMO","RA","BK4022","BK4588","BK4585","BK4007","BK4510","LU1829250122.USD","BK4085","IXHL","BK4097","BK4563","AHI","GSK.UK"],"gpt_icon":1},{"id":"2477169465","title":"AdAlta secures top talent to lead AdCella and AdSolis as boost in clinical activity looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2477169465","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477169465?lang=en_us&edition=fundamental","pubTime":"2024-10-24 09:34","pubTimestamp":1729733682,"startTime":"0","endTime":"0","summary":"AdAlta boosts leadership of subsidiaries with appointments of two consultant chief medical officers. AdCella’s Kevin Lynch will support selection of in-licensed cellular immunotherapies and the design and execution of Phase 1 clinical trials. The AdSolis consultant CMO will provide strategic oversight for the clinical development of AD-214 and lead execution of its Phase 2 trials","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/10/1AD_captains-1200_x_675-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/10/1AD_captains-1200_x_675-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/adalta-secures-top-talent-to-lead-adcella-and-adsolis-as-boost-in-clinical-activity-looms/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["CMO"],"gpt_icon":0},{"id":"2477949586","title":"Press Release: Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2477949586","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477949586?lang=en_us&edition=fundamental","pubTime":"2024-10-23 20:01","pubTimestamp":1729684860,"startTime":"0","endTime":"0","summary":"Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting. Dr Jacobs was one of 10 participants at the meeting selected to deliver a 4-minute presentation. In her presentation Dr. Jacobs reminded the attendees that cytisine has been a smoking cessation treatment for decades in Eastern and Central Europe. She also pointed out that although the efficacy and safety profile has been well-established for this older marketed product, the treatment involves a complex 25-day titration regimen. Dr. Jacobs highlighted Achieve's redevelopment of this drug into a novel treatment for nicotine addiction, now known as cytisinicline. This new cytisinicline product features a revised formulation and tablet strength, easier streamlined dosing schedule, and extended treatment durations, demonstrating strong efficacy and excellent safety in the completed Phase 3 trials. In closing, Dr. Jacobs urged the FDA to re-assess how new drugs are being approve","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACHV","CMO"],"gpt_icon":0},{"id":"2477131324","title":"Closing Bell: WiseTech drags again; 29Metals sinks 20pc on copper output","url":"https://stock-news.laohu8.com/highlight/detail?id=2477131324","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477131324?lang=en_us&edition=fundamental","pubTime":"2024-10-23 14:18","pubTimestamp":1729664338,"startTime":"0","endTime":"0","summary":"ASX edges slightly up by 0.12pc as traders rethink rate cuts. Consumer staples shine while gold miners gain amid global tensions. 29Metals plunges after cash reserve drop and production decline","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/10/29Metals-plunges-after-cash-reserve-drop-and-production-decline.Picture-via-Getty-Images-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/10/29Metals-plunges-after-cash-reserve-drop-and-production-decline.Picture-via-Getty-Images-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/news/closing-bell-wisetech-drags-again-29metals-sinks-20pc-on-copper-output/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["CMO"],"gpt_icon":0},{"id":"2477329820","title":"ASX Small Caps Lunch Wrap: ASX up, and things are pretty quiet for a Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2477329820","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477329820?lang=en_us&edition=fundamental","pubTime":"2024-10-23 10:43","pubTimestamp":1729651395,"startTime":"0","endTime":"0","summary":"ASX up slightly by lunchtime on a quietish news day . Supermarkets up, InfoTech down as Codan sheds value. Small Cap winners include Eastern Metals and Arrow Minerals. Local markets have opened broadly higher this morning, with the ASX 200 benchmark up about 0.3% early in the session, bouncing nicely after yesterday’s sell-down.There’s not a whole heap of major news kicking about – it’s almost a little bit too quiet today – but let’s jump in to what we’ve got…","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/10/2024-10-23-LW-000-640x361.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/10/2024-10-23-LW-000-640x361.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/news/asx-small-caps-lunch-wrap-asx-up-and-things-are-pretty-quiet-for-a-wednesday/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["CMO"],"gpt_icon":0},{"id":"2476040282","title":"Nxera Pharma to Host R&D Day 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2476040282","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476040282?lang=en_us&edition=fundamental","pubTime":"2024-10-18 17:38","pubTimestamp":1729244280,"startTime":"0","endTime":"0","summary":"Nxera Pharma Co., Ltd. will hold an R&D Day on 6 November 2024 at 16:30 JST. The meeting will be held virtually via Zoom webinar.Please clickhereto pre-register for the event.Date: Wednesday, 6 November 2024Time: 16:30 – 18:00 JST . Presenters:Chris Cargill, President and CEO Dr. Matt Barnes, Executive Officer, President of Nxera Pharma UK and Head of R&DDr. Makoto Sugita, Executive Officer, Chief Medical Officer  and President of Nxera Pharma JapanHironoshin Nomura, Executive Officer, CFO. Presentation slides will be made available by 16:00 JST  on 6 November through the investor section of the Company’s Home Pagehere.This press release contains forward-looking statements, including statements about the discovery, development, and commercialization of products. Various risks may cause Nxera Pharma Group’s actual results to differ materially from those expressed or implied by the forward looking statements, including: adverse results in clinical development programs; failure to obtain ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/z9kcAFGwDzfNUW6QCgONwA--~B/aD0xMzgxO3c9NDA5NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/eb8b35e4636bcafaff8513420e990173","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/z9kcAFGwDzfNUW6QCgONwA--~B/aD0xMzgxO3c9NDA5NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/eb8b35e4636bcafaff8513420e990173"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nxera-pharma-host-r-d-093800951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HST","SOLTF","BK4528","BK4007","BK4585","UK","BK4205","BK4218","CMO","BK4588","BK4181","BK4233"],"gpt_icon":0},{"id":"2476382121","title":"Press Release: First Citizens Bank Names Chief Marketing Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2476382121","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476382121?lang=en_us&edition=fundamental","pubTime":"2024-10-17 21:00","pubTimestamp":1729170000,"startTime":"0","endTime":"0","summary":"Michelle Draper, former Silicon Valley Bank CMO and 30-year financial industry veteran, to lead marketing and client experience. RALEIGH, N.C., Oct. 17, 2024 /PRNewswire/ -- First Citizens Bank today announced the appointment of Michelle Draper to Chief Marketing Officer . Most recently, Draper served as Chief Marketing and Sales Strategy Officer of Silicon Valley Bank , a division of First Citizens Bank.In her role serving the First Citizens enterprise, Draper leads a marketing organization nationwide dedicated to building upon the company's customer-centric vision that delivers solutions, experiences and capabilities based on customers' needs.Before joining SVB, Draper spent nearly two decades at Charles Schwab as the company grew from 3,000 to 14,000 employees. As a member of the senior management team responsible for business-to-business enterprises, she oversaw a range of functions from advertising to brand management and client communications. She also served as a director of inv","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","03160","TM","BK4207","LU0006061336.USD","BK4585","BK4555","BK4588","FCNCA","BK4211","FCNCB","LU0072461881.USD","BK4589","LU0162691827.USD","CMO"],"gpt_icon":0},{"id":"2475095605","title":"89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2475095605","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475095605?lang=en_us&edition=fundamental","pubTime":"2024-10-15 20:30","pubTimestamp":1728995400,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Oct.  15, 2024  (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/15/2963199/0/en/89bio-to-Present-New-Analyses-from-ENLIVEN-Phase-2b-Pegozafermin-Trial-in-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-at-AASLD-The-Liver-Meeting-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMO"],"gpt_icon":0},{"id":"2473547327","title":"Binance CMO Rachel Conlan Talks Regional Growth, Crypto Adoption, and Community","url":"https://stock-news.laohu8.com/highlight/detail?id=2473547327","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473547327?lang=en_us&edition=fundamental","pubTime":"2024-10-08 19:30","pubTimestamp":1728387000,"startTime":"0","endTime":"0","summary":"Rachel Conlan, CMA at Binance, discusses the company's growth, reaching 219 million users and its role in expanding crypto adoption.Poland is emerging as a key market for Binance, with high crypto adoption and strong community engagement through Binance Angels.During ETHWarsaw, held on 5-6 September 2024, BeInCrypto had the exclusive opportunity to attend a special event organized by Binance, where key representatives shared insights into the company’s growth and future plans. Among the highlights of the event was an insightful interview with Rachel Conlan, Binance’s Global Chief Marketing Officer, who played a crucial role in shaping the company’s global marketing strategy.The event, dedicated to select media outlets, offered an intimate setting for discussions on the crypto landscape, particularly in markets like Poland and LATAM. Rachel Conlan shared her thoughts on Poland’s growing role in the European crypto ecosystem, citing high adoption rates and a thriving tech-savvy populatio","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/10/Rachel-Conlan_Binance-850x478.png","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/10/Rachel-Conlan_Binance-850x478.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/rachel-conlan-on-binance-expansion/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4588","APT.USD.CC","LU1880383366.USD","TON.USD.HKCC","CMO","SG9999002463.SGD","COIN","IE0008368742.USD","TCEHY","RNDR.USD.HKCC","BK4579","BK4531","LU0106959298.USD","BK4524","BK4558","BK4220","BK4505","IE00BGV7N243.SGD","ETH.USD.HKCC","BK4504","APT.USD.HKCC","RC","BABA","BK4585","BK4551","BK4503","LU1688375341.USD","BK4526","BK4122","TON.USD.CC","BK4509","BK4110"],"gpt_icon":1},{"id":"2473428446","title":"Optimi Health appoints Parisa Zamiri as CMO, Tom Reilly as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2473428446","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473428446?lang=en_us&edition=fundamental","pubTime":"2024-10-08 19:15","pubTimestamp":1728386150,"startTime":"0","endTime":"0","summary":"Opthea (OPTHF) announced three senior hires as the Company continues to prepare for the sozinibercept Phase 3 topline data readouts of COAST antici...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-appoints-parisa-zamiri-as-cmo-tom-reilly-as-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-appoints-parisa-zamiri-as-cmo-tom-reilly-as-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPTHF","OPT","CMO","BK4139"],"gpt_icon":0},{"id":"2473682440","title":"Opthea Appoints Chief Medical Officer and Chief Financial Officer as Company Prepares for Phase 3 Topline Data Readouts in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2473682440","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473682440?lang=en_us&edition=fundamental","pubTime":"2024-10-08 19:00","pubTimestamp":1728385200,"startTime":"0","endTime":"0","summary":"Parisa Zamiri, MD, PhD, and Tom Reilly respectively appointed CMO and CFO Anand Sundaram appointed Vice President Marketing MELBOURNE, Australia and PRINCETON, N.J., Oct.  08, 2024  (GLOBE NEWSWIRE) -","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/08/2959555/0/en/Opthea-Appoints-Chief-Medical-Officer-and-Chief-Financial-Officer-as-Company-Prepares-for-Phase-3-Topline-Data-Readouts-in-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GFS","LU0109392836.USD","BK4575","LU0642271901.SGD","BK4534","LU1242518857.USD","IE00B5949003.HKD","CMO","BK4554","LU0823421416.USD","LU1951200564.SGD","LU1064131342.USD","LU0198837287.USD","BK4139","LU1803068979.SGD","LU1242518931.SGD","LU0127658192.USD","LU1988902786.USD","LU0823421333.USD","IE00BMPRXR70.SGD","OPT","BK4588","LU2264538146.SGD","LU1880398554.USD","LU0082616367.USD","LU0823434740.USD","LU0056508442.USD","LU1880398471.USD","LU1923623000.USD","BK4585","BK4512","LU2458330169.SGD","BK4573","LU0823434583.USD","LU1852331112.SGD","LU1303367103.USD","BK4532","LU2098885051.SGD","LU0081259029.USD","LU2458330243.SGD","IE0009356076.USD","CFO","LU1951198990.SGD","LU2250418816.HKD","LU1316542783.SGD","BK4566","BK4529","LU0979878070.USD","LU2360106780.USD"],"gpt_icon":1},{"id":"2473441026","title":"Press Release: Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2473441026","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473441026?lang=en_us&edition=fundamental","pubTime":"2024-10-08 18:15","pubTimestamp":1728382500,"startTime":"0","endTime":"0","summary":"Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Health. FRANKLIN, Tenn., Oct. 08, 2024  -- Counterpart Health, Inc. , a leading AI-powered physician enablement platform, today announced the appointment of David Tsay M.D., Ph.D as Chief Medical Officer . Dr. Tsay will play a key role in advancing Counterpart's clinical strategy and product roadmap for Counterpart Assistant, the company's proprietary AI-powered physician enablement software platform that empowers providers to deliver high-quality, cost-effective care. Counterpart is a subsidiary of Clover Health Investments, Corp.  .For companies interested in learning more about how Counterpart can reduce the tot","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","CLOV","BK4547","CMO"],"gpt_icon":0},{"id":"2473214909","title":"Allarity names Jeremy Graff as president, CDO, Jose Iglesias as consultant CMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2473214909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473214909?lang=en_us&edition=fundamental","pubTime":"2024-10-05 15:42","pubTimestamp":1728114161,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics (ALLR) announced several key leadership appointments to accelerate its clinical and strategic development. To further advance...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allarity-names-jeremy-graff-as-president-cdo-jose-iglesias-as-consultant-cmo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allarity-names-jeremy-graff-as-president-cdo-jose-iglesias-as-consultant-cmo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLR","BK4139","CMO"],"gpt_icon":0}],"pageSize":16,"totalPage":7,"pageCount":5,"totalSize":99}]}}